Stock Analysis
Primo Brands Corporation (PRMB) Stock Analysis
Primo Brands Corporation (PRMB) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Primo Brands Corporation (PRMB) currently has an AIQ Score of 33/100, indicating a bearish setup. Value is the strongest factor at 50/100. Quality is the weakest current factor at 18/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
PRMB at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $20.75 |
| AIQ Score | 33/100 |
| Overall View | Bearish |
| Technical Analysis Consensus | Strong Sell |
| Market Cap | $8.32B |
| P/E Ratio | 18.05 |
| Forward P/E | — |
| EPS | $0.19 |
| Revenue TTM | $1.8B |
| Dividend Yield | 0.00% |
| Beta | 0.72 |
| Volume | 4.82M |
| 52-week range | $14.36-$26.21 |
| RSI 14 | 25.87 |
| 50-Day SMA | $23.38 |
| 200-Day SMA | $20.84 |
| Analyst Price Target | $27.38 |
| Next Earnings | Nov 5, 2026 |
Create a free account to keep researching stocks
You have viewed 2 stock pages in the last 24 hours. Create a free account to keep researching current evidence.
PRMB
OverviewPRMB Stock Analysis Summary
Primo Brands Corporation (PRMB) currently has an AIQ Score of 33/100, indicating a bearish setup. Value is the strongest factor at 50/100. Quality is the weakest current factor at 18/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a bearish regime, PRMB has AIQ Score of 33/100 with Value base of 50/100 and fading Quality at 18/100. Wait for component alignment before adding exposure.
Value (50/100) leads while Quality (18/100) lags. This cross-factor spread creates entry timing uncertainty.
Consumer Defensive · 0.92% stock move · PRMB classified in Beverages - Non-Alcoholic.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is PRMB Bullish or Bearish Right Now?
PRMB currently has a bearish overall setup. Value is the strongest factor at 50/100, while Quality is weakest at 18/100. The current evidence suggests a defensive setup.
- - Analyst target implies +31.95% upside from the latest quote.
- - Momentum is weak at 24/100.
- - Risk Resilience is weak at 44/100.
- - Price is -0.41% below its 200-day SMA.
- - Technical consensus has more sell votes than buy votes (36 vs 8).
Current Consensus
PRMB's Technical Analysis Consensus is currently Strong Sell, with 8 buy, 1 neutral, and 36 sell votes. PRMB's 14-day RSI is 25.87, which places the stock in an oversold momentum range. PRMB's beta is 0.72, indicating lower market sensitivity than the broad market.
What Changed in PRMB?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the PRMB Outlook?
The current bearish outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
PRMB Decision Framework
Public evidence layers, setup checks, and risk context for Primo Brands Corporation.
Primo Brands Corporation (PRMB) Stock Analysis
Primo Brands Corporation has an AIQ Score of 33/100 in a Defensive regime. Value is strongest at 50/100. Beta is 0.72, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | PRMB is in a Defensive AIQ regime with score 33/100. |
| Signal Conflict | The primary conflict is that value leads at 50/100 while quality lags at 18/100. |
| Factor Evidence | Momentum 24/100 · Value 50/100 · Quality 18/100 · Risk 44/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 50/100.
Momentum is 24/100 and RSI (14) is 25.9.
PRMB is in a Defensive regime at 33/100.
Risk factor is 44/100 with beta 0.72 and annual volatility 49.46%.
Current conflict: value leads at 50/100 while quality lags at 18/100.
PRMB Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
PRMB Fundamentals
PRMB valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
PRMB Technical Analysis
PRMB technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
PRMB Stock Catalysts
Track PRMB earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
PRMB Dividend Analysis
PRMB dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
PRMB Financial Data
PRMB revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
PRMB Risk Analysis
PRMB volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
PRMB Stock News
PRMB stock news, market tone, recent headlines, and catalyst context.
PRMB vs Gene Editing / Genomics / Biotech Peers
Current peer cohort: PRMB · RARE · RCKT · RGNX · RIGL. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| PRMB Current stock | 33/100 | 50/100 | 24/100 | 44/100 | -0.15 | 49.46% | Current |
| RARE Ultragenyx Pharmaceutical | 43/100 | 50/100 | 22/100 | 21/100 | -0.52 | 80.54% | PRMB vs RARE |
| RCKT Rocket Pharmaceuticals | 36/100 | — | 37/100 | 48/100 | 0.37 | 71.62% | PRMB vs RCKT |
| RGNX REGENXBIO | 44/100 | 56/100 | 26/100 | 55/100 | 0.33 | 93.31% | PRMB vs RGNX |
| RIGL Rigel Pharmaceuticals | 74/100 | 63/100 | 67/100 | 59/100 | 0.65 | 64.58% | PRMB vs RIGL |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts7 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching PRMB
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for PRMB
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
PRMB Stock FAQ
What is PRMB stock price today?
Primo Brands Corporation's current stock price is $20.75. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is PRMB bullish or bearish right now?
PRMB's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is PRMB's market cap?
PRMB's market cap is $8.32B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is PRMB's current P/E ratio?
PRMB's current P/E ratio is 18.05 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is PRMB's RSI?
PRMB's 14-day RSI is 25.87 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is PRMB above its 50-day and 200-day moving averages?
PRMB is -11.24% from its 50-day SMA and -0.41% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is PRMB's next earnings date?
PRMB's next earnings date is currently listed as Nov 5, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does PRMB pay a dividend?
PRMB's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.